Prevalence and risk factors of age-related macular degeneration in Korea: The Korea National Health and Nutrition Examination Survey 2010-2011

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 2, 2013, Pages 1101-1108

  Cho, Bum Joo ^a,b   Heo, Jang Won ^a,b   Kim, Tae Wan ^a,c   Ahn, Jeeyun ^a,c   Chung, Hum ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Age related macular degeneration; Prevalence; Risk factor

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; CREATININE; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; HEMOGLOBIN A1C; HEPATITIS B SURFACE ANTIGEN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VITAMIN D;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLINDNESS; EYE FUNDUS; EYE PHOTOGRAPHY; FEMALE; GEOGRAPHIC ATROPHY; HEALTH SURVEY; HUMAN; HYPERMETROPIA; KOREA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; RISK FACTOR; SEX RATIO; SMOKING; SYSTOLIC BLOOD PRESSURE; VERY ELDERLY; VISUAL ACUITY TESTING EQUIPMENT; VISUAL IMPAIRMENT;

AGE-RELATED MACULAR DEGENERATION; PREVALENCE; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GEOGRAPHIC ATROPHY; HEPATITIS B SURFACE ANTIGENS; HUMANS; HYPEROPIA; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; REPUBLIC OF KOREA; RISK FACTORS; WET MACULAR DEGENERATION;

EID: 84896696954     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-13096     Document Type: Article

References (41)

1. Pascolini D, Mariotti SP, Pokharel GP, et al. 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic Epidemiol. 2004;11:67-115.
2. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1992;99:933-943.
3. Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995;102:205-210.
4. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of agerelated maculopathy in Australia: the Blue Mountains Eye Study. Ophthalmology. 1995;102:1450-1460.
5. Varma R, Fraser-Bell S, Tan S, Klein R, Azen SP. Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino eye study. Ophthalmology. 2004;111:1288-1297.
6. Kawasaki R, Yasuda M, Song SJ, et al. The prevalence of agerelated macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology. 2010;117:921-927.
7. Tomany SC, Wang JJ, Van Leeuwen R, et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology. 2004;111:1280-1287.
8. Chakravarthy U, Wong TY, Fletcher A, et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol. 2010;10:31.
9. Xu L, Li Y, Zheng Y, Jonas JB. Associated factors for age related maculopathy in the adult population in China: the Beijing eye study. Br J Ophthalmol. 2006;90:1087-1090.
10. Butt AL, Lee ET, Klein R, et al. Prevalence and risks factors of age-related macular degeneration in Oklahoma Indians: the Vision Keepers Study. Ophthalmology. 2011;118:1380-1385.
11. Cheung CM, Tai ES, Kawasaki R, et al. Prevalence of and risk factors for age-related macular degeneration in a multiethnic Asian cohort. Arch Ophthalmol. 2012;130:480-486.
12. Kawasaki R, Wang JJ, Ji GJ, et al. Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: the Funagata study. Ophthalmology. 2008;115: 1376-1381, 1381. e1-e2.
13. Korea National Statistical Office. Preliminary Results of the 2010 Population and Housing Census. Available at: http:// kostat.go.kr/portal/english/news/1/9/index.board?bmode= read&aSeq=245048. Published 2011. Accessed August 2, 2013.
14. Yoon KC, Mun GH, Kim SD, et al. Prevalence of eye diseases in South Korea: data from the Korea National Health and Nutrition Examination Survey 2008-2009. Korean J Ophthalmol. 2011;25:421-433.
15. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39: 367-374.
16. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health. 1989;79:340-349.
17. Klein R, Klein BE, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 2003;110:1273-1280.
18. van Leeuwen R, Ikram MK, Vingerling JR, Witteman JC, Hofman A, de Jong PT. Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci. 2003;44:3771-3777.
19. Klein R, Cruickshanks KJ, Nash SD, et al. The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol. 2010;128:750-758.
20. Jonasson F, Arnarsson A, Sasaki H, Peto T, Sasaki K, Bird AC. The prevalence of age-related maculopathy in Iceland: Reykjavik eye study. Arch Ophthalmol. 2003;121:379-385.
21. Piermarocchi S, Segato T, Scopa P, et al. The prevalence of agerelated macular degeneration in Italy (PAMDI) study: report 1. Ophthalmic Epidemiol. 2011;18:129-136.
22. Roh MI, Kim JH, Byeon SH, Koh HJ, Lee SC, Kwon OW. Estimated prevalence and risk factor for age-related maculopathy. Yonsei Med J. 2008;49:931-941.
23. Song SJ, Youm DJ, Chang Y, Yu HG. Age-related macular degeneration in a screened South Korean population: prevalence, risk factors, and subtypes. Ophthalmic Epidemiol. 2009;16:304-310.
24. Klein R, Chou CF, Klein BE, Zhang X, Meuer SM, Saaddine JB. Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol. 2011;129:75-80.
25. Li Y, Xu L, Wang YX, You QS, Yang H, Jonas JB. Prevalence of age-related maculopathy in the adult population in China: the Beijing eye study. Am J Ophthalmol. 2008;146:329.
26. Gemmy Cheung CM, Li X, Cheng CY, et al. Prevalence and risk factors for age-related macular degeneration in Indians: a comparative study in Singapore and India. Am J Ophthalmol. 2013;155:764-773.
27. Chen SJ, Cheng CY, Peng KL, et al. Prevalence and associated risk factors of age-related macular degeneration in an elderly Chinese population in Taiwan: the Shihpai Eye Study. Invest Ophthalmol Vis Sci. 2008;49:3126-3133.
28. Yang K, Liang YB, Gao LQ, et al. Prevalence of age-related macular degeneration in a rural Chinese population: the Handan Eye Study. Ophthalmology. 2011;118:1395-1401.
29. Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology. 2012;119:571-580.
30. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology. 2001;108:697-704.
31. Kawasaki R, Wang JJ, Aung T, et al. Prevalence of age-related macular degeneration in a Malay population: the Singapore Malay Eye Study. Ophthalmology. 2008;115:1735-1741.
32. Fraser-Bell S, Wu J, Klein R, Azen SP, Varma R. Smoking, alcohol intake, estrogen use, and age-related macular degeneration in Latinos: the Los Angeles Latino Eye Study. Am J Ophthalmol. 2006;141:79-87.
33. Goldberg DM. Structural, functional, and clinical aspects of gamma-glutamyltransferase. CRC Crit Rev Clin Lab Sci. 1980; 12:1-58.
34. Turgut O, Tandogan I. Gamma-glutamyltransferase to determine cardiovascular risk: shifting the paradigm forward. J Atheroscler Thromb. 2011;18:177-181.
35. Turgut O, Yilmaz A, Yalta K, Karadas F, Birhan Yilmaz M. Gamma-glutamyltransferase is a promising biomarker for cardiovascular risk. Med Hypotheses. 2006;67:1060-1064.
36. Sarli B, Baktir AO, Saglam H, et al. The relation of serum gamma-glutamyl transferase levels and coronary collateral circulation in patients with chronic coronary total occlusion. Coron Artery Dis. 2013;24:298-302.
37. Lee DH, Jacobs DR Jr. Association between serum gammaglutamyltransferase and C-reactive protein. Atherosclerosis. 2005;178:327-330.
38. Lee DS, Evans JC, Robins SJ, et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2007;27:127-133.
39. Donnelly CA, Seth J, Clayton RM, Phillips CI, Cuthbert J, Prescott RJ. Some blood plasma constituents correlate with human cataract. Br J Ophthalmol. 1995;79:1036-1041.
40. Moss SE, Klein R, Klein BE, Jensen SC, Meuer SM. Alcohol consumption and the 5-year incidence of age-related maculopathy: the Beaver Dam eye study. Ophthalmology. 1998;105: 789-794.
41. You QS, Xu L, Yang H, et al. Five-year incidence of age-related macular degeneration: the Beijing Eye Study. Ophthalmology. 2012;119:2519-2525.